World's Best Scientists 2026 revealed!
Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
132
Citations
101148
World Ranking
2266
National Ranking
1281

Gilles Montalescot publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gilles Montalescot sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 995 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gilles Montalescot D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gilles Montalescot sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 132 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Gilles Montalescot is affiliated with Université Paris Cité in France and has contributed extensively to the field of Medicine, with a particular focus on Cardiology and Cardiovascular Medicine. Their research portfolio encompasses a wide range of topics within cardiovascular health, including acute myocardial infarction, antiplatelet therapy, coronary interventions, and cardiac imaging.

The scientist's recent published papers cover several high-impact areas and include the following:

  • "Statin therapy is associated with lower prevalence of gut microbiota dysbiosis" (2020) in Nature
  • "Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction" (2021) in the New England Journal of Medicine
  • "Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology" (2020) in Nature Communications
  • "Combinatorial, additive and dose-dependent drug-microbiome associations" (2021) in Nature
  • "Antithrombotic Therapy for Patients With Left Ventricular Mural Thrombus" (2020) in the Journal of the American College of Cardiology

Montalescot collaborates frequently with several notable co-authors, such as:

  • Paul Guedeney
  • Johanne Silvain
  • Michel Zeitouni
  • Mathieu Kerneïs
  • Éric Vicaut

The researcher publishes predominantly in cardiovascular-focused journals. The most frequent publication venues include:

  • European Heart Journal
  • Journal of the American College of Cardiology
  • JACC: Cardiovascular Interventions
  • Archives of Cardiovascular Diseases
  • American Heart Journal

Montalescot's scientific work spans multiple subfields within medicine, namely:

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Radiology, Nuclear Medicine and Imaging
  • Internal Medicine

The main topics explored throughout their career include:

  • Acute Myocardial Infarction Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Coronary Interventions and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Imaging and Diagnostics
  • Venous Thromboembolism Diagnosis and Management
  • Cardiovascular and Diving-Related Complications

Best Publications

  • Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

    Stephen D. Wiviott;Eugene Braunwald;Carolyn H. McCabe;Gilles Montalescot

  • 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

    Gilles Montalescot;Udo Sechtem;Stephan Achenbach;Felicita Andreotti

  • Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events

    Deepak L. Bhatt;Keith A.A. Fox;Werner Hacke;Peter B. Berger

  • ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment eleva...

    C. W. Hamm;J.-P. Bassand;S. Agewall;J. Bax

  • 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

    Stephan Windecker;Philippe Kolh;Fernando Alfonso;Jean-Philippe Collet

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

    Marco Valgimigli;Héctor Bueno;Robert A Byrne;Jean-Philippe Collet

  • Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation

    Marc S. Sabatine;Christopher P. Cannon;C. Michael Gibson;Jose L. López-Sendón

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

    Marco Valgimigli;Héctor Bueno;Robert A. Byrne;Jean-Philippe Collet

  • Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction

    Gilles Montalescot;Paul Barragan;Olivier Wittenberg;Patrick Ecollan

  • Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.

    Gilles Montalescot;Stephen D Wiviott;Eugene Braunwald;Sabina A Murphy

  • Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

    Laurent Bonello;Udaya S. Tantry;Rossella Marcucci;Ruediger Blindt

  • Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.

    Jessica L. Mega;Tabassome Simon;Jean Philippe Collet;Jeffrey L. Anderson

  • Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.

    Stephen D. Wiviott;Dietmar Trenk;Andrew L. Frelinger;Michelle O’Donoghue

  • Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

    Jean-Philippe Collet;Jean-Sébastien Hulot;Anna Pena;Eric Villard

  • Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)

    Mauro Moscucci;Keith A. A. Fox;Christopher P. Cannon;Werner Klein

  • Bedside monitoring to adjust antiplatelet therapy for coronary stenting.

    Jean-Philippe Collet;Thomas Cuisset;Grégoire Rangé;Guillaume Cayla

  • PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

    Holger Thiele;Ibrahim Akin;Marcus Sandri;Georg Fuernau

  • Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study.

    Marc S. Sabatine;Christopher P. Cannon;C. Michael Gibson;Jose L. López-Sendón

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.

    Marco Valgimigli;Héctor Bueno;Robert A. Byrne;Jean-Philippe Collet

  • Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

    Marc S. Sabatine;Christopher P. Cannon;C. Michael Gibsonn;Jose L. Lopez-Sendon

Frequent Co-Authors

Jean-Philippe Collet
Jean-Philippe Collet Sorbonne University
Eric Vicaut
Eric Vicaut Université Paris Cité
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Christian W. Hamm
Christian W. Hamm University of Giessen
Uwe Zeymer
Uwe Zeymer University of Göttingen
Keith A.A. Fox
Keith A.A. Fox University of Edinburgh
Kurt Huber
Kurt Huber Sigmund Freud University Vienna
Steven R. Steinhubl
Steven R. Steinhubl Scripps Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine or healthcare, there are many flexible online options beyond the traditional path to becoming a physician. Students looking for entry-level healthcare roles may consider accredited medical billing and coding schools online with financial aid, which offer an accessible way to enter the medical field with valuable administrative skills.

For prospective nurses who wish to avoid lengthy or challenging entrance exams, you might be interested in exploring nursing schools that don't require teas. These programs make pursuing a nursing degree more accessible for a wider range of students.

Those looking for managerial roles can find respected healthcare administration associate degree online programs which prepare graduates for fast-growing leadership positions in hospitals and clinics.

Experienced nurses hoping to advance their careers and scope of practice may want to consider asn to fnp programs, which provide bridge pathways from an associate degree in nursing to becoming a family nurse practitioner.

With so many different online degrees available, you can find a healthcare career fit that matches your skills and ambitions, whether you’re seeking direct patient care, administration, or specialized clinical roles.

Best Scientists Citing Gilles Montalescot

Trending Scientists

Recently Published Articles